Welcome To SteroidScience.org

A comprehensive resource of relevant human studies of anabolic steroids for bodybuilders, athletes and students.

Treatment of 34 cases of chronic aplastic anemia using prepared Rehmannia polysaccharide associated with stanozolol

. Friday, 11 July 2008
  • Agregar a Technorati
  • Agregar a Del.icio.us
  • Agregar a DiggIt!
  • Agregar a Yahoo!
  • Agregar a Google
  • Agregar a Meneame
  • Agregar a Furl
  • Agregar a Reddit
  • Agregar a Magnolia
  • Agregar a Blinklist
  • Agregar a Blogmarks

Zhongguo Zhong Xi Yi Jie He Za Zhi. 1998 Jun;18(6):351-3.

[Treatment of 34 cases of chronic aplastic anemia using prepared Rehmannia
polysaccharide associated with stanozolol]

[Article in Chinese]

Yuan A, Liu C, Huang X.

Second Affiliated Hospital of Henan Medical University, Zhengzhou 450003.

OBJECTIVE: To investigate the effect and side effect of prepared Rehmannia
polysaccharide (PRP) associated with stanozolol in treating chronic aplastic
anemia (CAA).

METHODS: Thirty-four cases of CAA were treated by PRP liquid
associated with stanozolol, course of 3 week treatment, and control group (17
cases of CAA) was treated by stanozolol alone.

RESULTS: Effective rate was 85.3%
in treatment group, and that of control group was 58.8%, there was significant
difference between them (P < 0.05). Symptom remission of treatment group was
earlier than that of control group, symptom scoring between two groups, the
difference was highly significant (P < 0.01). Blood cell had a distinct elevation
after treatment with PRP associated with stanozolol, and had a significant
difference in comparing with pre-treatment in treatment group (P < 0.01). Side
effect of PRP was not found during treatment of CAA.

CONCLUSIONS: PRP associated
with stanozolol to treat CAA has an additional effect, it can accelerate symptom
remission without any additional side effect

0 comments: